GlassScriptPhysician profile
Jessica Mitchell
NPI 1700293149
$2,560.40
in general payments reported to CMS, 2019-2025
11 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $798 · 2022: $998 · 2023: $394 · 2024: $45.17 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,745.19 | 2021-2023 | Proclaim, Prodigy |
| Boston Scientific Corporation | $409.82 | 2021-2025 | Infinion 16, General - Therapies, Artisan |
| Collegium Pharmaceutical, INC. | $126.47 | 2021-2023 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.87 | 2021-2023 | Relistor |
| Arbor Pharmaceuticals, INC. | $53.95 | 2021 | |
| Forte Bio-Pharma LLC | $36.58 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.01 | 2022 | |
| Amgen INC. | $17.37 | 2021 | |
| Biodelivery Sciences International, INC. | $16.95 | 2021 | |
| Idorsia Pharmaceuticals US INC | $16.65 | 2022 | |
| Merz Pharmaceuticals, LLC | $15.54 | 2023 | Xeomin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.